Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:concept
|
| gptkbp:basisFor |
gptkb:National_Essential_Medicines_Lists
|
| gptkbp:category |
complementary medicines
core medicines |
| gptkbp:criteria |
public health relevance
comparative cost-effectiveness evidence on efficacy and safety |
| gptkbp:definedIn |
gptkb:World_Health_Organization
|
| gptkbp:documentType |
gptkb:WHO_Model_List_of_Essential_Medicines
|
| gptkbp:example |
gptkb:amoxicillin
gptkb:paracetamol gptkb:insulin gptkb:oral_rehydration_salts antiretroviral drugs |
| gptkbp:firstPublished |
1977
|
| gptkbp:goal |
universal access to medicines
|
| gptkbp:listUpdated |
every two years
|
| gptkbp:purpose |
meet priority health care needs
|
| gptkbp:relatedTo |
gptkb:Universal_Health_Coverage
gptkb:Sustainable_Development_Goals |
| gptkbp:updated |
gptkb:World_Health_Organization
|
| gptkbp:usedBy |
health systems worldwide
|
| gptkbp:bfsParent |
gptkb:beta-lactam_antibiotics
gptkb:Antibiotics |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Essential Medicines
|